Leaders of the Antibody sector: An interview with SpectraMAb's CSO, Georg Fey

Leaders of the Antibody sector: An interview with SpectraMab’s CSO, Georg Fey

There is undoubtedly a great deal of research going on within the antibody space, a significant number of therapeutics in the clinic and a lot of upcoming developments to watch out for. So in preparation for the European Antibody Congress 2014, we took some time out to conduct interviews with key members of the speaker faculty who are leaders in …